コンテンツへスキップ
Merck
  • Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.

Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.

Expert opinion on drug delivery (2014-04-08)
Osama A A Ahmed, Mohsen I Afouna, Khalid M El-Say, Ashraf B Abdel-Naim, Alaa Khedr, Zainy M Banjar
要旨

To optimize and use of glimepiride (GMD)-loaded self-nanoemulsifying delivery systems (SNEDs) for the preparation of transdermal patches. Mixture design was utilized to optimize GMD-loaded SNEDs in acidic and aqueous pH media. Optimized GMD-loaded SNEDs were used in the preparation of chitosan (acidic) and hydroxypropyl methyl cellulose (HPMC) (aqueous) films. The prepared optimized formulations were investigated for ex vivo skin permeation, for in vivo hypoglycemic activity and for their pharmacokinetic parameters using animal model. The optimized formulations showed flux value of (2.88 and 4.428 μg/cm(2)/h) through rat skin for chitosan and HPMC films, respectively. The pattern of GMD release from both formulations was in favor of Higuchi and approaching zero order models. The n values for Korsmeyer-Peppas equation were characteristic of anomalous (non-Fickian) release mechanism. Moreover, HPMC patches have shown significant reductions (p < 0.05) in blood glucose levels; (213.33 ± 15.19) mg/100 ml from the base-line measurement after 12 h of application. Optimized GMD SNEDs patches were found to improve GMD skin permeability and the essential pharmacokinetic parameters. Further extensive pre/clinical studies are necessary prior to use transdermal GMD as a valuable alternative to peroral dosage forms with improved bioavailability, longer duration of action and more patient convenience.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
キトサン, low molecular weight
Sigma-Aldrich
キトサン, medium molecular weight
Sigma-Aldrich
メチルセルロース, viscosity: 4,000 cP
Sigma-Aldrich
キトサン, high molecular weight
Sigma-Aldrich
キトサン, from shrimp shells, ≥75% (deacetylated)
Sigma-Aldrich
メチルセルロース, viscosity: 15 cP, BioReagent, suitable for cell culture
Sigma-Aldrich
キトサン, from shrimp shells, practical grade
Sigma-Aldrich
メチルセルロース, viscosity: 1,500 cP
Sigma-Aldrich
メチルセルロース, viscosity: 15 cP
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, average Mn ~86,000
Sigma-Aldrich
メチルセルロース, viscosity: 25 cP
Sigma-Aldrich
キトサン エビ殻由来, low-viscous
Sigma-Aldrich
グリメピリド, ≥98% (HPLC), solid
Sigma-Aldrich
メチルセルロース, 27.5-31.5% (Methoxyl content), viscosity: 400 cP
Sigma-Aldrich
Methocel® A15 LV, 27.5-31.5% methoxyl basis
USP
グリメピリド, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Methocel® A4M, viscosity 3000-5500 mPa.s, 2 % in H2O(20 °C)
Sigma-Aldrich
メチルセルロース, meets USP testing specifications, 26.0-33.0% (methoxyl group, on Dry Basis), viscosity: 400 cP
Sigma-Aldrich
Methocel® A15C, medium viscosity, Methoxyl content 27.5-31.5 %
Sigma-Aldrich
メチルセルロース, 26.0-33.0% (Methoxy group (dry basis)), meets USP testing specifications, viscosity: 1,500 cP
システム適合性用グリメピリド, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
メチルセルロース, tested according to Ph. Eur.
グリメピリド, European Pharmacopoeia (EP) Reference Standard